Blessing Hospital
Acute Care Hospitals · Voluntary non-profit - Private
1005 Broadway St
Quincy, IL 62301
- Emergency services
- Medicare overall rating: 4 of 5 stars
At a glance
- Clinicians who list this hospital
- 586
- Physicians (MD and DO)
- 375
- Residents and fellows in training (full-time equivalents, fiscal year 2024)
- 17
- Medical groups
- 15+
Quality and patient experience
- Medicare overall rating (of 5)
- 4
- Patient survey rating (of 5)
- 3
- Patients who would definitely recommend it (national average 71%)
- 67%
Compared with the national rate
| Measures | Better | Same | Worse |
|---|---|---|---|
| Deaths after treatment | 0 | 8 | 0 |
| Safety of care (infections, complications) | 2 | 5 | 0 |
| Readmissions and return visits | 0 | 11 | 0 |
Number of Medicare quality measures where this hospital’s rate is statistically better than, the same as (no different from), or worse than the national rate.
What patients said
- Doctors communicated well 2 of 5 stars
- Nurses communicated well 4 of 5 stars
- Explained medicines 2 of 5 stars
- Discharge information 4 of 5 stars
- Clean 4 of 5 stars
- Quiet at night 4 of 5 stars
From 431 patient surveys (HCAHPS), period ending 09/30/2025.
Medicare “birthing-friendly” hospital: takes part in a maternity care quality program and follows recommended safety practices.
Source: CMS Care Compare (Hospital General Information; Patient survey HCAHPS). Ratings describe the hospital overall, not individual doctors.
Physicians by specialty
- Family Medicine 78
- Internal Medicine 38
- Radiology 37
- Anesthesiology 16
- Emergency Medicine 16
- Orthopedic Surgery 14
- Neurology 12
- Cardiology 12
- Gastroenterology 10
- General Surgery 10
- OB-GYN (Obstetrics & Gynecology) 9
- Psychiatry 8
- Nephrology (Kidney) 7
- Interventional Cardiology 7
- Pulmonology 7
- Critical Care Medicine 7
- Urology 7
- Pathology 6
- ENT (Otolaryngology) 6
- Hospitalist 6
- Endocrinology & Diabetes 5
- Interventional Radiology 5
- Hematology & Oncology 5
- Rheumatology 4
- Cardiac Electrophysiology 4
- Vascular Surgery 4
- Cardiothoracic Surgery 3
- Infectious Disease 3
- Dermatology 3
- Radiation Oncology 3
- Neurosurgery 3
- Hospice & Palliative Medicine 2
- Geriatric Medicine 2
- Plastic Surgery 2
- Hand Surgery 2
- Sports Medicine 2
- Medical Oncology 2
- Heart Failure & Transplant Cardiology 2
- Trauma Surgery 1
- Joint Replacement Surgery 1
- Facial Plastic Surgery 1
- Physical Medicine & Rehabilitation (PM&R) 1
- Pain Medicine 1
- Spine Surgery 1
- Neuroradiology 1
Other clinicians
Medical groups whose clinicians work here
- Blessing Hospital 347
- Quincy Physicians and Surgeons Clinic, PLLC 102
- Hannibal Regional Healthcare System Inc 43
- Specialists in Medical Imaging Sc 33
- Board of Trustees of Southern Illinois University 15
- Pike County Memorial Hospital 14
- Scotland County Memorial Hospital 12
- Hurley Medical Center 12
- Memorial Hospital Association 12
- Louisville Radiology Imaging Consultants PLLC 11
- Blessingcare Corporation 10
- Schuyler County Hospital District 6
- Mark Twain Association for Mental Health Inc 6
- Henry County Health Center Inc 5
- Mcdonough County Hospital District 5
Number of each group’s clinicians who list this hospital.
Industry-funded research here
Drug and device companies reported $869,772 in research payments to this hospital in 2025 for 10 studies.
- Capivasertib plus Palbociclib plus Fulvestrant for HR/HER2 Advanced Breast Cancer CAPItello 292.
AstraZeneca Pharmaceuticals LP · $355,483 - A phase 3 randomized double blind placebo controlled study of PF06821497 mevrometostat with enzalutamide in metastatic castration resistant prostate cancer MEVPRO2
Pfizer Inc. · $194,773 - Ion Registry BLE Patient Visits Monitoring and Misc Fees
Intuitive Surgical Operations, Inc. · $105,857 - A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fi…
Janssen Research & Development, LLC · $100,440 - A Phase III Randomized Double blind Multicenter Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum based Chemotherapy for the First line Treatment of Patients with Metastatic Non squamous Non …
AstraZeneca Pharmaceuticals LP · $24,000 - Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals As · $24,000 · Recruiting - A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
Janssen Research & Development, LLC · $23,709 - A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
Janssen Research & Development, LLC · $18,825 - A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
Janssen Research & Development, LLC · $12,294 - A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination with Durvalumab and Carboplatin Versus Pembrolizumab in Combination with Platinum-based Chemotherapy f…
AstraZeneca Pharmaceuticals LP · $10,391
From CMS Open Payments research payments to this hospital as a teaching hospital. Payments to affiliated universities or research foundations are reported under those names. All industry-funded trials →
Sources: CMS Hospital General Information and Doctors and Clinicians Facility Affiliation (Care Compare), CMS certification number 140015. Counts are clinicians who list this hospital with Medicare; they include part-time and visiting clinicians and aren’t staff totals. Residents and beds are from the hospital’s Medicare cost report. Ratings are Medicare’s, not ours.